December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Augmentation of Choroidal Neovascularization in a Laser Induced Mouse Model by PEDF
Author Affiliations & Notes
  • TA Ferguson
    Department of Ophthalmology & Visual Sciences Washington University School of Medicine St Louis MO
  • H Kaplan
    Department of Ophthalmology & Visual Sciences University of Louisville Louisville KY
  • T Tezel
    Department of Ophthalmology & Visual Sciences Washington University School of Medicine St Louis MO
  • O Volpert
    Northwestern University Chicago IL
  • R Barriero
    Department of Ophthalmology & Visual Sciences Washington University School of Medicine St Louis MO
  • R Schadlu
    Department of Ophthalmology & Visual Sciences Washington University School of Medicine St Louis MO
  • Footnotes
    Commercial Relationships   T.A. Ferguson, None; H. Kaplan, None; T. Tezel, None; O. Volpert, None; R. Barriero, None; R. Schadlu, None. Grant Identification: Support: NIH Grant EY12826, Research to Prevent Blindness, and Foundation for Fighting Blindness.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2756. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      TA Ferguson, H Kaplan, T Tezel, O Volpert, R Barriero, R Schadlu; Augmentation of Choroidal Neovascularization in a Laser Induced Mouse Model by PEDF . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2756.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Examine the effect of PEDF (Pigment epithelium derived growth factor) on laser induced choroidal neovascularization (CNV). Methods: Adult C57Bl/6 were anesthetized and 4 laser spots were placed in each quadrant of the fundus using a Krypton Red Laser (614 nm, 100µm, 0.5 sec, 200mW). Animals were treated with varying doses of PEDF administered using a mini osmotic pump implanted subcutaneously. Seven days following laser treatment mice were perfused with 3% FITC high molecular weight dextran, enucleated, and neovascularization analyzed by confocal microscopy. Data are recorded as incidence of CNV per laser spot, absolute area of the CNV complex, and relative area of CNV (which compares the area of CNV to the area of the laser spot). Results: Mice receiving lower doses of PEDF (totaling 45-90 µg over the experimental period) had significantly reduced incidences, absolute areas, and relative areas of CNV. Mice receiving higher doses of PEDF (300-400 µg) had significantly increased CNV. Intermediate doses (180-200 µg) of PEDF had no effect. Conclusion: PEDF demonstrates opposing effects on CNV. While low does can inhibit CNV, high does can increase the development of neovascularization. These results suggest the effects of PEDF on neovascularization are more complex than originally believed, and that caution should be exercised when PEDF therapies are considered.

Keywords: 346 choroid: neovascularization • 308 age-related macular degeneration • 483 neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×